takrozem 0.1 % voide
pierre fabre dermatologie - tacrolimusum - voide - 0.1 % - takrolimuusi
tolerak 40 mg/g emulsiovoide
pierre fabre medicament - fluorouracil - emulsiovoide - 40 mg/g - fluorourasiili
ebvallo
pierre fabre medicament - tabelecleucel - lymphoproliferative disorders - ebvallo is indicated as monotherapy for treatment of adult and paediatric patients 2 years of age and older with relapsed or refractory epstein-barr virus positive post-transplant lymphoproliferative disease (ebv+ ptld) who have received at least one prior therapy. for solid organ transplant patients, prior therapy includes chemotherapy unless chemotherapy is inappropriate.
methylprednisolone orion 125 mg injektiokuiva-aine, liuosta varten
orion corporation - methylprednisolone sodium succinate - injektiokuiva-aine, liuosta varten - 125 mg - metyyliprednisoloni
methylprednisolone orion 250 mg injektiokuiva-aine, liuosta varten
orion corporation - methylprednisolone sodium succinate - injektiokuiva-aine, liuosta varten - 250 mg - metyyliprednisoloni
methylprednisolone orion 500 mg injektiokuiva-aine, liuosta varten
orion corporation - methylprednisolone sodium succinate - injektiokuiva-aine, liuosta varten - 500 mg - metyyliprednisoloni
methylprednisolone orion 1000 mg injektiokuiva-aine, liuosta varten
orion corporation - methylprednisolone sodium succinate - injektiokuiva-aine, liuosta varten - 1000 mg - metyyliprednisoloni